Drug intelligence / Profile preview

[18F]F-RESCA-WWH347

Development stage
Unknown
Lead developer
Renji Hospital
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes, Antibody Fragments → Engineered Antibody Formats → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

[18F]F-RESCA-WWH347 is a novel radiopharmaceutical probe designed for immunoPET imaging, specifically targeting the GPA33 antigen. It utilizes the Al^18^F-RESCA (Aluminum fluoride-restrained complexing agent) method to label heat-sensitive biomolecules with fluorine-18, enabling high-specificity PET imaging of tumors expressing GPA33, such as those found in colorectal and other digestive system cancers. The RESCA chelator allows for mild and efficient radiolabeling at room temperature, preserving the integrity of sensitive proteins or antibody fragments. This probe is being investigated primarily for its ability to visualize and quantify tumor burden in patients with digestive system carcinomas using immunoPET/CT scans[1][3][9].

02

Targets

GPA33 (Glycoprotein A33)

Beyond the preview

Go deeper on [18F]F-RESCA-WWH347.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on [18F]F-RESCA-WWH347.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call